News & Announcements

Weil Advised Walgreens Boots Alliance, Inc. in the $1.4B Acquisition of PharMerica Corporation by KKR

Weil advised Walgreens Boots Alliance, Inc. in the merger agreement pursuant to which the newly formed company controlled by KKR, with Walgreens Boots Alliance as a minority investor, acquired PharMerica Corporation, a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services. The all-cash transaction was valued at approximately $1.4 billion including the assumption or repayment of debt. The transaction closed December 07, 2017, upon which PharMercia became a private company.

The Weil team that advised Walgreens Boots Alliance included Antitrust/Competition Co-Head Steven Newborn, Antitrust partner Jeff White and counsel Vadim Brusser; M&A partner Michael Aiello; Banking & Finance partner Damian Ridealgh; Executive Compensation & Benefits Head Paul Wessel; Tax partner Helyn Goldstein; Corporate associates Vladislava Rebeiz, Andrea Ryken and Philip Wolf; Banking & Finance associate Thomas Mastoras; Executive Compensation & Benefits associate Aaron Cha; and Tax associate Eric Remijan.